Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

An 8-year-old Saudi boy was diagnosed with a rare genetic disorder causing hair loss, skin issues, and light sensitivity.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Hair loss significantly affects emotional and social well-being.

Hair loss significantly affects emotional and social well-being.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

New genetic discoveries may lead to better treatments for alopecia areata.

Early treatment can reverse hair loss from dermal fillers.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Sarcoidosis can cause scarring hair loss on the scalp, which is rare.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Some drugs can cause permanent hair loss, though it's rare.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Two rare bald spots on the back of the scalp were found to be lupus, not alopecia areata.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.